Exploring the Clinical Features and Treatment Outcomes of Autoimmune Encephalitis in Pediatric Patients: A Cross-Sectional Analysis
DOI:
https://doi.org/10.70749/ijbr.v3i5.1198Keywords:
Pediatric Encephalitis, Autoimmune Encephalitis, Anti-NMDAR, Immunotherapy, Treatment OutcomesAbstract
Background: Autoimmune encephalitis is an increasingly recognized cause of acute neurological dysfunction in children and can present with a wide spectrum of neuropsychiatric and neurological symptoms. Prompt diagnosis and treatment are important for favourable outcomes, especially in resource constrained settings. Objectives: This study was an objective to explore the clinical features, diagnostic profiles and treatment outcomes of pediatric patients with autoimmune encephalitis in a tertiary care hospital in Lahore, Pakistan. Methods: It is a cross sectional study that was carried out at a tertiary care hospital in Karachi from January to December 2024. A total of 52 children aged 1 to 18 years with confirmed autoimmune encephalitis were included. Clinical presentations, antibody subtype, neuroimaging, cerebrospinal fluid (CSF) analysis, treatment, and outcome at discharge and at three months clinic follow up were recorded. Results: Behavioral changes (76.9%), seizures (69.2%), altered consciousness (61.5%), and other (45.7%) were the most common presenting symptoms. The most frequent subtype was anti-NMDAR encephalitis (61.5%). EEG abnormalities were found in 80.8%, and pleocytosis in the CSF 67.3%. Corticosteroids were given to all patients and 76.9% received IVIG, 28.8% underwent plasmapheresis. Indeed, by three months, 80.8 percent of patients had full or nearly complete recovery, and 7.7 percent relapsed. Improved outcomes (p = 0.03) correlated with early initiation of immunotherapy. Conclusion: The range of symptoms seen with pediatric autoimmune encephalitis can make this entity a challenge to recognize, treat promptly, and mitigate the morbidity caused by this illness. An early diagnosis followed by aggressive immunotherapy is associated with favorable outcomes and demands heightened clinical awareness with standardization of management protocols.
Downloads
References
Santoro, J. D., Demakakos, P., He, S., Kumar, S., Murton, M., Tennigkeit, F., & Hemingway, C. (2024). A systematic review of the epidemiology of pediatric autoimmune encephalitis: Disease burden and clinical decision-making. Frontiers in Neurology, 15.
https://doi.org/10.3389/fneur.2024.1408606
Ancona, C., Masenello, V., Tinnirello, M., Toscano, L. M., Leo, A., La Piana, C., Toldo, I., Nosadini, M., & Sartori, S. (2022). Autoimmune encephalitis and other neurological syndromes with rare neuronal surface antibodies in children: A systematic literature review. Frontiers in Pediatrics, 10.
https://doi.org/10.3389/fped.2022.866074
Ford, H., Griffith, S., Warren, N., Swayne, A., Blum, S., Butzkueven, H., O'Brien, T. J., Velakoulis, D., Kulkarni, J., & Monif, M. (2022). Psychiatric manifestations of autoimmune encephalitis. Autoimmunity Reviews, 21(9), 103145.
https://doi.org/10.1016/j.autrev.2022.103145
Nagase, H., Yamaguchi, H., Tokumoto, S., Ishida, Y., Tomioka, K., Nishiyama, M., Nozu, K., & Maruyama, A. (2023). Timing of therapeutic interventions against infection-triggered encephalopathy syndrome: A scoping review of the pediatric literature. Frontiers in Neuroscience, 17.
https://doi.org/10.3389/fnins.2023.1150868
Olie, S. E., Staal, S. L., Van de Beek, D., & Brouwer, M. C. (2025). Diagnosing infectious encephalitis: A narrative review. Clinical Microbiology and Infection, 31(4), 522-528.
https://doi.org/10.1016/j.cmi.2024.11.026
Shalbafan, B. (2024). Perspective chapter: Red flags for syndromic epilepsy. Epilepsy During the Lifespan - Beyond the Diagnosis and New Perspectives.
https://doi.org/10.5772/intechopen.113765
Li, S., Yu, M., Cheng, J., Bai, W., & Di, W. (2022). Ovarian teratoma related anti-N-methyl-D-aspartate receptor encephalitis: A case series and review of the literature. World Journal of Clinical Cases, 10(16), 5196-5207.
https://doi.org/10.12998/wjcc.v10.i16.5196
Joseph, K., Van der Hock, S., Seth, I., Hapangama, N., Gibson, L., Cuomo, R., Rozen, W. M., & Dhupar, N. (2024). Association of ovarian teratoma with anti-N-methyl-D-aspartate receptor encephalitis: A case report and narrative review. Archives of Gynecology and Obstetrics.
https://doi.org/10.1007/s00404-024-07779-6
Wright, M. A., Trandafir, C. C., Nelson, G. R., Hersh, A. O., Inman, C. J., & Zielinski, B. A. (2021). Diagnosis and management of suspected pediatric autoimmune encephalitis: A comprehensive, multidisciplinary approach and review of literature. Journal of Child Neurology, 37(4), 303-313.
https://doi.org/10.1177/08830738211064673
Awashra, A., Milhem, F., Khaled, A., Hamshari, R., Nabresi, N., Ahmad, O., & Rabee, A. (2024). Atypical presentation of autoimmune encephalitis in a pediatric patient: Diagnostic delays and treatment responses. Journal of Medicine, Surgery, and Public Health, 4, 100144.
https://doi.org/10.1016/j.glmedi.2024.100144
Endres, D., Von Zedtwitz, K., Nickel, K., Runge, K., Maier, A., Domschke, K., Salzer, U., Prüss, H., Venhoff, N., & Van Elst, L. T. (2024). Association of rheumatological markers with neuronal antibodies, cerebrospinal fluid, electroencephalography, and magnetic resonance imaging findings in 224 patients with psychotic syndromes. Brain, Behavior, and Immunity, 119, 482-493.
https://doi.org/10.1016/j.bbi.2024.04.001
Pankratz, B., Von Zedtwitz, K., Runge, K., Denzel, D., Nickel, K., Schlump, A., Pitsch, K., Maier, S., Dersch, R., Voderholzer, U., Domschke, K., Tebartz van Elst, L., Schiele, M. A., Prüss, H., & Endres, D. (2022). Cerebrospinal fluid findings in adult patients with obsessive-compulsive disorder: A retrospective analysis of 54 samples. The World Journal of Biological Psychiatry, 24(4), 292-302.
https://doi.org/10.1080/15622975.2022.2104457
Kumar, P., Zelena, D., & Gautam, A. (2023). Neurological disorders and challenges in their Theranostics. Theranostic Applications of Nanotechnology in Neurological Disorders, 1-29.
https://doi.org/10.1007/978-981-99-9510-3_1
Flanagan, E. P., Geschwind, M. D., Lopez-Chiriboga, A. S., Blackburn, K. M., Turaga, S., Binks, S., Zitser, J., Gelfand, J. M., Day, G. S., Dunham, S. R., Rodenbeck, S. J., Clardy, S. L., Solomon, A. J., Pittock, S. J., McKeon, A., Dubey, D., Zekeridou, A., Toledano, M., Turner, L. E., … Irani, S. R. (2023). Autoimmune encephalitis misdiagnosis in adults. JAMA Neurology, 80(1), 30.
https://doi.org/10.1001/jamaneurol.2022.4251
Dinoto, A., Ferrari, S., & Mariotto, S. (2022). Treatment options in refractory autoimmune encephalitis. CNS Drugs, 36(9), 919-931.
https://doi.org/10.1007/s40263-022-00943-z
Mahadeen, A. Z., Carlson, A. K., Cohen, J. A., Galioto, R., Abbatemarco, J. R., & Kunchok, A. (2024). Review of the longitudinal management of autoimmune encephalitis, potential biomarkers, and novel therapeutics. Neurology Clinical Practice, 14(4).
https://doi.org/10.1212/cpj.0000000000200306
Kanters, S., Ball, G., Kahl, B., Wiesinger, A., Limbrick-Oldfield, E. H., Sudhindra, A., Snider, J. T., & Patel, A. R. (2023). Clinical outcomes in patients relapsed/refractory after ≥2 prior lines of therapy for follicular lymphoma: A systematic literature review and meta-analysis. BMC Cancer, 23(1).
https://doi.org/10.1186/s12885-023-10546-6
Nguyen, L., & Wang, C. (2023). Anti-NMDA receptor autoimmune encephalitis: Diagnosis and management strategies. International Journal of General Medicine, 16, 7-21.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
